Mass balance and pharmacokinetics of an oral dose of 14C‐napabucasin in healthy adult male subjects

Abstract This phase 1, open‐label study assessed14C‐napabucasin absorption, metabolism, and excretion, napabucasin pharmacokinetics, and napabucasin metabolites (primary objectives); safety/tolerability were also evaluated. Eight healthy males (18-45 years) received a single oral 240‐mg napabucasin...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Xiaoshu Dai (Author), Michael D. Karol (Author), Matthew Hitron (Author), Marjie L. Hard (Author), John Evan Blanchard (Author), Nicola C. J. E. Eraut (Author), Natalie Rich (Author), Brandon T. Gufford (Author)
Format: Knjiga
Izdano: Wiley, 2021-02-01T00:00:00Z.
Teme:
Online dostop:Connect to this object online.
Oznake: Označite
Brez oznak, prvi označite!

Internet

Connect to this object online.

3rd Floor Main Library

Podrobnosti zaloge 3rd Floor Main Library
Signatura: A1234.567
Kopija 1 Prosto